NCT01459185View on ClinicalTrials.gov

A Feasibility Study of Oral Adjuvant Chemotherapy With S-1

PHASE2CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

May 31, 2008

Study Completion Date

March 31, 2012

Conditions
Non-small Cell Lung Cancer
Interventions
DRUG

S-1

Chemotherapy comprised eight courses (4-week administration, 2-week withdrawal; total 1 year) of S-1 at 80-120 mg/body/day according to body surface area (BSA)

Trial Locations (1)

852-8501

Division of Surgical Oncology, Nagasaki University Graduate School of BIomedical Sciences, Nagasaki

All Listed Sponsors
lead

Tomoshi Tsuchiya

OTHER

NCT01459185 - A Feasibility Study of Oral Adjuvant Chemotherapy With S-1 | Biotech Hunter | Biotech Hunter